
Yale New Haven Hospital Earns Apex Designation
The American Association for Respiratory Care recognized the hospital's respiratory care team for the 2027-2028 period.
This page covers diagnosis, treatment breakthroughs and public health impact in New Haven. Reporting follows emerging medical conditions, regulatory alerts and the research behind evolving care protocols.

The American Association for Respiratory Care recognized the hospital's respiratory care team for the 2027-2028 period.
Live Poll
Do you feel your local healthcare facilities are adequately equipped with the latest medical technology?
The medical facility adds a 9-ton PET/MRI scanner to enhance patient diagnostics.

The Connecticut musician passed away after a six-year battle with stage 4 prostate cancer.

New Haven-based IRulya Therapeutics will discuss its ongoing drug development pipeline at an upcoming industry event.
A New Haven jury found Yale New Haven Hospital liable for permanent eye damage during a 2019 brain surgery.

Live Poll
Do you feel your local government provides enough emergency medical equipment in public spaces?
The Connecticut-based company provides life-saving technology to aid city emergency responses.

Day to day, that means disease outbreaks and public health alerts, new treatment approvals, clinical trial results and risk factor studies. Coverage reaches across the city and the communities around it. New Haven public health policy often shifts in response to localized clusters, making surveillance and reporting on clusters central to the work. Hospital system capacity and regional access to specialized care remain the most consistent factors shaping how these health stories unfold.